IRVINE — Birtcher Medical Systems Inc., the surgical products manufacturer, received permission on Wednesday to market its "SureClean" line of surgical instruments.
The go-ahead from the U.S. Food and Drug Administration prompted the Irvine company's stock to surge 50 cents a share in Nasdaq trading, closing at $4.375 a share.
The new product line is targeted for minimally invasive surgery--where there are fewer cuts--and is designed to cut down on surgeon hand fatigue. A new design allows each instrument to be easily taken apart for easier cleaning and sterilization.
Sales of the product line are expected to significantly boost third-quarter revenues, the company said.
Birtcher develops, manufactures and markets medical products for hospital operating rooms, surgery centers and doctors' offices worldwide.